Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial
Edward S. Kim(The University of Texas MD Anderson Cancer Center), Vera Hirsh(McGill University Health Centre), Tony Mok(Chinese University of Hong Kong), Mark A. Socinski(University of North Carolina at Chapel Hill), Radj Gervais(Centre François Baclesse), Yi‐Long Wu(Guangdong Provincial People's Hospital), Long-Yun Li(Peking Union Medical College Hospital), Claire Watkins(AstraZeneca (United Kingdom)), Mark V. Sellers(AstraZeneca (United Kingdom)), Elizabeth Lowe(AstraZeneca (United States)), Yan Sun(Peking University Cancer Hospital), Mei‐Lin Liao(Shanghai Chest Hospital), Kell Østerlind(Herlev Hospital), Martin Reck(LungenClinic Grosshansdorf), Alison Armour(AstraZeneca (United Kingdom)), Frances A. Shepherd(University of Toronto), Scott M. Lippman(The University of Texas MD Anderson Cancer Center), Jean‐Yves Douillard
Cited by 1,243
Abstract
Related Papers
No related papers found
Powered by citation graph analysis